Unknown

Dataset Information

0

Finding the Best Antiviral Regimen for COVID-19: A Double-Center Retrospective Cohort Study of 207 Cases in Hunan, China.


ABSTRACT: Objective:To compare the efficacy of 3/4-drugs' group with 1-drug's or 2-drugs' groups in coronavirus disease 2019 (COVID-19). Methods:We included 207 patients confirmed with COVID-19. We compared the viral clearance rate and discharge rate at day 7, 14, 21 and 28, and median time of viral clearance and length of hospitalization in patients treated with 3/4, 1 or 2 drugs. Results:The viral clearance rates of the 3/4-drugs group at day 7, 14 and 21 were significantly lower than those in the 1-drug's or 2-drugs' groups (P < 0.05). The median viral clearance days in 3/4-drugs group (13.5 days) were longer than 1-drug's or 2-drugs' groups (both were 9 days) (P < 0.001). The patients' discharge rates in the 3/4-drugs group at day 14 and 21 were significantly lower than that in the 1-drug's or 2 drugs' group (P < 0.05). The median length of hospitalization in the 3/4-drugs group was 17 days, which was significantly longer than 11 days in the 1-drug group and 13 days in the 2-drug group (P < 0.05). Conclusion:The efficacy of 1 or 2 antiviral drugs was similar in COVID-19, and 3/4-drug regimens were not associated with clinical improvement. Corticosteroid treatment and more serious disease were also risk factors for viral clearance and patients'discharge.

SUBMITTER: Hu X 

PROVIDER: S-EPMC7429915 | biostudies-literature | 2020 Jul-Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Finding the Best Antiviral Regimen for COVID-19: A Double-Center Retrospective Cohort Study of 207 Cases in Hunan, China.

Hu Xingsheng X   Hu Chunhong C   Zhong Ping P   Wen Yajing Y   Yang Yong Y   Chen Juan J   Chen Xiangyu X  

Dose-response : a publication of International Hormesis Society 20200701 3


<h4>Objective</h4>To compare the efficacy of 3/4-drugs' group with 1-drug's or 2-drugs' groups in coronavirus disease 2019 (COVID-19).<h4>Methods</h4>We included 207 patients confirmed with COVID-19. We compared the viral clearance rate and discharge rate at day 7, 14, 21 and 28, and median time of viral clearance and length of hospitalization in patients treated with 3/4, 1 or 2 drugs.<h4>Results</h4>The viral clearance rates of the 3/4-drugs group at day 7, 14 and 21 were significantly lower t  ...[more]

Similar Datasets

| S-EPMC7649871 | biostudies-literature
| S-EPMC8423773 | biostudies-literature
| S-EPMC7155762 | biostudies-literature
| S-EPMC3052659 | biostudies-other
| S-EPMC4427968 | biostudies-literature
| S-EPMC4712051 | biostudies-other
| S-EPMC6148411 | biostudies-literature
| S-EPMC8055570 | biostudies-literature
| S-EPMC8509968 | biostudies-literature
| S-EPMC7947481 | biostudies-literature